Differential regulation of adenylyl cyclase in fibroblasts from sporadic and familial Alzheimerʼs disease cases with PS1 and APP mutations
- 26 May 1997
- journal article
- research article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 8 (8) , 2031-2035
- https://doi.org/10.1097/00001756-199705260-00045
Abstract
β-ADRENOCEPTOR- and forskolin-45 cyclase activities were determined in primary skin fibroblasts established from patients with sporadic Alzheimer's disease (AD) and from individuals with familial APP KM670/671NL, PS1 M146V and PS1 H163Y mutations. Our data showed a significantly decreased β-adrenoceptor-stimulated adenylyl cyclase activity in fibroblasts from sporadic AD compared with age-matched controls (p < 0.001, Student's unpaired t-test). In contrast, both β-adrenoceptor- and forskolin-stimulated adenylyl cyclase activities were significantly increased in fibroblasts bearing PS1 M146V and PS1 H163Y mutations compared with controls (p < 0.01 and p < 0.05, respectively). No differences were seen between cell lines with and without the Swedish APP KM670/671NL double mutation. We suggest that various gene mutations associated with AD have different consequences for the regulation of adenylyl cyclase signal transduction in this disorder.Keywords
This publication has 5 references indexed in Scilit:
- Membrane Topology of the C. elegans SEL-12 PresenilinNeuron, 1996
- Notch SignalingScience, 1995
- Calmodulin plays a dominant role in determining neurotransmitter regulation of neuronal adenylate cyclaseJournal of Cellular Biochemistry, 1988
- Epinephrine-induced cyclic AMP production in skin fibroblasts from patients with dementia of Alzheimer type and controlsNeurobiology of Aging, 1985
- The regulatory subunit of adenylate cyclase interacts with cytoskeletal componentsNature, 1981